Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21830390)

  • 1. Comparison of clinicopathological features and hRad21 expression between telomerase-dependent and telomerase-independent colorectal cancer.
    Yi BQ; Zhao B; Wang ZJ
    Hepatogastroenterology; 2011; 58(107-108):785-9. PubMed ID: 21830390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
    Lam AK; Saleh S; Smith RA; Ho YH
    Hum Pathol; 2008 Aug; 39(8):1229-33. PubMed ID: 18547619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
    Lam AK; Ong K; Ho YH
    Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres].
    Yi BQ; Zhao B; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):67-71. PubMed ID: 18197499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomerase activity in colorectal carcinoma and its relationship to clinicopathological findings].
    Iida A; Yamaguchi A; Ohtaki N; Goi T; Hirose K; Nakagawara G
    Nihon Rinsho; 1998 May; 56(5):1214-7. PubMed ID: 9613125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
    J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
    Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
    Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
    Lam KY; Law S; Luk JM; Wong J
    J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity of blood samples and recurrence of colorectal cancer.
    Ohnishi T; Watanabe T; Nozawa H; Kitayama J; Nagawa H
    Hepatogastroenterology; 2008; 55(86-87):1513-8. PubMed ID: 19102333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
    Simsek BC; Pehlivan S; Karaoglu A
    Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer].
    Ando Y
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1700-9. PubMed ID: 2277618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
    J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multi-variate regression analysis of clinicopathological characteristics and prognosis of colorectal cancer].
    Wang JP; Yang ZL; Wang L; Dong WG; Huang YH; Qin JZ; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):59-61. PubMed ID: 12678990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.